Anixa Biosciences's total assets for Q1 2025 were $18.91M, a decrease of -12.44% from the previous quarter. ANIX total liabilities were $2.19M for the fiscal quarter, a -18.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.